FDA Adverse Event Injury Summary report: N

COREVALVE TRANSCATHETER AORTIC VALVE

MDR report key: 6940340 · Received October 11, 2017

Report

Report Number
2025587-2017-01812
Event Type
Injury
Date Received
October 11, 2017
Date of Event
March 13, 2015
Report Date
September 21, 2017
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: AVERSA, E. MD. NEW CONDUCTION DISTURBANCES AND PACEMAKER INDICATIONS AFTER COREVALVE® TRANSCATHETER AORTIC VALVE REPLACEMENT. INCIDENCE AND FOLLOW UP IN A SINGLE CENTER EXPERIENCE. ARCHIVOS DE CARDIOLOGIA DE MEXICO; (2015) 85(4):278-83. DOI: 10.1016/J.A CMX.2014.12.001 EARLIEST DATE OF E-PUBLISH/PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION, IT CANNOT BE DETERMINED WHETHER THIS EVENT HAS BEEN PREVIOUSLY REPORTED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REVIEW REGARDING THE INCIDENCE OF NEW CONDUCTION DISTURBANCES AFTER THE IMPLANT OF A TRANSCATHETER BIOPROSTHETIC AORTIC VALVE. ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN 2009 AND 2012. THE STUDY POPULATION INCLUDED 32 PATIENTS AND WAS PREDOMINANTLY MALE; MEAN AGE 80 YEARS. ALL PATIENTS WERE IMPLANTED WITH A COREVALVE TRANSCATHETER BIOPROSTHETIC AORTIC VALVE. SERIAL NUMBERS WERE NOT PROVIDED. AMONG ALL PATIENTS, ADVERSE EVENTS INCLUDED: LEFT BUNDLE BRANCH BLOCK (LBBB), RIGHT BUNDLE BRANCH BLOCK (RBBB), PROLONGATED QRS SEGMENT, COMPLETE HEART BLOCK (CHB), PERMANENT PACEMAKER AND HIGH AND/OR LOW IMPLANT POSITIONS NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
720044 COREVALVE TRANSCATHETER AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION CRS

Patients

Seq Age Sex Outcome Treatment
1 80 YR Required Intervention